Findings

What do systematic reviews say?

670 questions · 686 findings · 338 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 349 · 50.9%GRADE not reported 70 · 10.2%Very low 75 · 10.9%Low 75 · 10.9%Moderate 87 · 12.7%High 30 · 4.4%

Augmentation of current antidepressant (SSRI) with ziprasidone (40 mg/d to 160 mg/d) vs augmentation of current antidepressant (SSRI) with placebo or continue on SSRI monotherapy

Quality of life ‐ not measured · treatment‐resistant depression in adults

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treatment‐resistant depression in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fluoxetine vs placebo

Health‐related quality of life · overweight or obese adults

The review found no eligible studies for this question.

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phamacotherapies that specifically target ammonia vs placebo or non‐absorbable disaccharides

Health‐related quality of life · adults with cirrhosis and hepatic encephalopathy

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in… 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

5‐alpha reductase inhibitors vs placebo

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phytotherapy vs Another topical agent or placebo

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Botulinum toxin type A vs placebo

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Allopurinol vs placebo

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Chinese medicine vs placebo or usual care

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prophylactic plasma transfusion before surgery/invasive procedures vs no prophylactic plasma transfusion before surgery/invasive procedures (colloid, crystalloid, placebo, or no treatment)

Quality of life ‐ not reported · patients undergoing non‐cardiac surgery/invasive procedures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing… 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acarbose vs placebo

Health‐related quality of life · people at increased risk for developing type 2 diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotics vs placebo

Quality of life ‐ not measured · participants with cancer treated with chemotherapy

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Probiotics vs placebo

Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)

The review found no eligible studies for this question.

1 finding from 1 review

Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs placebo

Improvement in quality of life · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vitamin E vs placebo

Quality of life ‐ not measured · MCI

The review found no eligible studies for this question.

1 finding from 1 review

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vitamin E + vitamin C vs placebo

Quality of life ‐ not measured · MCI

The review found no eligible studies for this question.

1 finding from 1 review

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc vs placebo

Health‐related quality of life · Patients with taste disturbances (dysgeusia/hypogeusia; idiopathic, zinc-deficient, or secondary to chronic renal failure)

1 finding from 1 review

Interventions for managing taste disturbances 2017 · Cochrane All outcomes
Results (health-related quality of life): None of the studies reported data on health-related quality of life. Heckmann 2005 (zinc) reported that signs of depression were less severe (Beck Depression Inventory P<0.05;…
1 study
GRADE not reported

Thrombopoietin mimetics vs placebo

Health‐related quality of life · Adult patients with myelodysplastic syndromes and thrombocytopenia

The review found no eligible studies for this question.

1 finding from 1 review

Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ursodeoxycholic acid vs placebo

Health‐related quality of life · people with primary sclerosing cholangitis

1 finding from 1 review

Pharmacological interventions for primary sclerosing cholangitis 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 198 participants
Very low

Desmopressin vs placebo

Quality of life ‐ not reported

The review found no eligible studies for this question.

2 findings from 1 review

Desmopressin for treating nocturia in men 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Desmopressin for treating nocturia in men 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo

Quality of life ‐ not reported · People with a haematological disorder

1 finding from 1 review

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders 2016 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported